Reaction
Nasal Pruritus reporting signals
As of the last recalculation, Nasal Pruritus appears in 1,225 FAERS reports alongside 16 co-occurring drug terms. The strongest observed disproportionality signal is IOHEXOL (PRR 39.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Iohexol | 19 | 39.5 | 39.6 |
| Eptinezumab-Jjmr | 11 | 20.7 | 20.7 |
| Fexofenadine Hydrochloride | 25 | 19.9 | 20.0 |
| Omalizumab | 79 | 16.8 | 16.8 |
| Fluticasone Furoate | 11 | 15.6 | 15.6 |
| Levocetirizine Dihydrochloride | 18 | 12.9 | 12.9 |
| Azelastine | 13 | 12.4 | 12.4 |
| Fexofenadine | 11 | 11.4 | 11.4 |
| Triamcinolone Acetonide | 19 | 10.6 | 10.6 |
| Sacubitril And Valsartan | 65 | 10.0 | 10.0 |
| Loratadine And Pseudoephedrine Sulfate | 4 | 8.6 | 8.6 |
| Crisaborole | 3 | 5.3 | 5.3 |
| Fremanezumab-Vfrm | 3 | 4.4 | 4.4 |
| Nirmatrelvir And Ritonavir | 10 | 3.2 | 3.2 |
| Dupilumab | 77 | 2.8 | 2.8 |
| Evolocumab | 18 | 1.9 | 1.9 |